论文信息 - Epidemiology of Polypharmacy in the General Population: 27-Year Prospective Cohort Study. - 字舞流文

Epidemiology of Polypharmacy in the General Population: 27-Year Prospective Cohort Study.

Brenda C T Kieboom | M. Ikram | M. Ikram | B. Kieboom | Silvan Licher | B. Stricker | L. Visser | G. Ziere | R. Ruiter | M. Ikram | M. Ikram

[1] Lana Fani,et al. Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: A population-based cohort study , 2019, PLoS medicine.

[2] K. Johnell,et al. An update on the clinical consequences of polypharmacy in older adults: a narrative review , 2018, Expert opinion on drug safety.

[3] G. Onder,et al. Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis , 2018, European Geriatric Medicine.

[4] C. Ryan,et al. Corrigendum , 2017, Age and Ageing.

[5] M. Marcucci,et al. Changes in clinical outcomes for community‐dwelling older people exposed to incident chronic polypharmacy: a comparison between 2001 and 2009 , 2016, Pharmacoepidemiology and drug safety.

[6] Paul Gallagher,et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.

[7] C. Campanelli. American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults , 2012 .

[8] F. Haaijer-Ruskamp,et al. The development of polypharmacy. A longitudinal study. , 2000, Family practice.

[9] J. Hallas,et al. PHARMACOEPIDEMIOLOGY AND PRESCRIPTION , 1997 .